Induction of glomerular lesions in the kidneys of mice infected with Vero toxin-producing Escherichia coli by lipopolysaccharide injection

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1374-1377

  Shimizu, Keiko ^a   Aiba, Yuji ^a,b   Tanaka, Kazuo ^a   Akatsuka, Akira ^a   Endoh, Masayuki ^a   Koga, Yasuhiro ^a  

^a TOKAI UNIVERSITY   (Japan)

^b Wakamoto Pharmaceutical Company Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; VEROTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; INTERFERON PRODUCTION; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; CAPILLARIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GERM-FREE LIFE; GLOMERULAR MESANGIUM; INTERFERON TYPE II; KIDNEY GLOMERULUS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; SHIGA-LIKE TOXIN I;

EID: 0033383365     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315008     Document Type: Article

References (13)

1. Karmali AM, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by Vero toxin producing Escherichia coli. J Infect Dis 1985; 151:775-82.
2. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int Suppl 1998; 66:S54-7.
3. Louise DC, Obrig TG. Shiga toxin associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor-α on human vascular endothelial cells in vitro. Infect Immun 1991; 59:4173-9.
4. Wadolkowski AE, Burris JA, O'Brien AD. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 1990; 58:2438-45.
5. Johnson WM, Lior H, Bezanson GS. Cytotoxic Escherichia coli O157:117 associated with hemorrhagic colitis in Canada. Lancet 1983; 1:76.
6. Yutsudo T, Nakabayashi N, Hirayama T, Tukeda Y. Purification and some properties of a Vero toxin from Escherichia coli O157H:7 that is immunologically unrelated to Shiga toxin. Microb Pathog 1987; 3:21-30.
7. Tamaki T, Akatsuka A, Tokunaga M, Ishige K, Uchiyama S, Shiraishi T. Morphological and biochemical evidence of muscle hyperplasia following weight-lifting exercise in rats. Am J Physiol 1997; 273:C246-56.
8. Tanaka K, Nakazawa H, Okada K, Umezawa K, Fukuyama N, Koga Y. Nitric oxide mediates marine cytomegalovirus-associated pneamonitis in lungs that are tree of the virus. J Clin Invest 1997, 100:1822-30.
9. Lovett HD, Ryan JL, Sterzel RB. Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J Immunol 1983; 131:2830-6.
10. Pfeilschifter J, Schwarzenbach H. Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett 1990; 273:185-7.
11. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 1997; 175:611-20.
12. Isogai E., Isogai H, Kimura K, et al. Role of tumor necrosis factor alpha in gnotobiotic mice infected with a Escherichia coli O157:H7 strain. Infect Immun 1998; 66:197-202.
13. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J Exp Med 1993; 177:1779-84.